126 related articles for article (PubMed ID: 9439402)
1. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.
Anjum MI; Chari R; Shetty A; Keen M; Palmer JH
Br J Urol; 1997 Dec; 80(6):885-8. PubMed ID: 9439402
[TBL] [Abstract][Full Text] [Related]
2. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
[TBL] [Abstract][Full Text] [Related]
3. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
[TBL] [Abstract][Full Text] [Related]
4. The UroLume endoprosthesis: a summary of the European and North American experience.
Oesterling JE
Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427
[TBL] [Abstract][Full Text] [Related]
5. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
[TBL] [Abstract][Full Text] [Related]
6. Urolume endourethral prosthesis for the treatment of urethral stricture disease: long-term results of the North American Multicenter UroLume Trial.
Badlani GH; Press SM; Defalco A; Oesterling JE; Smith AD
Urology; 1995 May; 45(5):846-56. PubMed ID: 7747374
[TBL] [Abstract][Full Text] [Related]
7. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
[TBL] [Abstract][Full Text] [Related]
8. The use of wallstents in patients with benign prostatic hyperplasia.
Guazzoni G; Montorsi F; Rigatti P
Arch Esp Urol; 1994 Nov; 47(9):927-31. PubMed ID: 7530950
[TBL] [Abstract][Full Text] [Related]
9. Prostatic UroLume Wallstent for urinary retention due to advanced prostate cancer: a 1-year followup study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Rigatti P
J Urol; 1994 Nov; 152(5 Pt 1):1530-2. PubMed ID: 7933192
[TBL] [Abstract][Full Text] [Related]
10. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
[TBL] [Abstract][Full Text] [Related]
11. Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.
Guazzoni G; Bergamaschi F; Montorsi F; Consonni P; Galli L; Matozzo V; Rigatti P
J Urol; 1993 Nov; 150(5 Pt 2):1641-6; discussion 1646-7. PubMed ID: 7692102
[TBL] [Abstract][Full Text] [Related]
12. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.
Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P
Prostate; 1994; 24(3):156-61. PubMed ID: 7509486
[TBL] [Abstract][Full Text] [Related]
13. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
[TBL] [Abstract][Full Text] [Related]
14. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
[TBL] [Abstract][Full Text] [Related]
15. The Urolume as a means of treating urinary outflow obstruction and its impact on waiting lists.
Schneider HJ; De Souza JV; Palmer JH
Br J Urol; 1994 Feb; 73(2):181-4. PubMed ID: 7510573
[TBL] [Abstract][Full Text] [Related]
16. Precautions and complications in the use of the urolume wallstent.
Parikh AM; Milroy EJ
Eur Urol; 1995; 27(1):1-7. PubMed ID: 7538081
[TBL] [Abstract][Full Text] [Related]
17. The UroLume stent in the management of benign prostatic hyperplasia.
Milroy E; Chapple CR
J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
[TBL] [Abstract][Full Text] [Related]
18. Prostatic stents for the treatment of benign prostatic hyperplasia.
Vanderbrink BA; Rastinehad AR; Badlani GH
Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103
[TBL] [Abstract][Full Text] [Related]
19. Self-expanding stent insertion for urethral strictures: a 10-year follow-up.
De Vocht TF; van Venrooij GE; Boon TA
BJU Int; 2003 May; 91(7):627-30. PubMed ID: 12699473
[TBL] [Abstract][Full Text] [Related]
20. Use of multiple urolume endourethral prostheses in complex bulbar urethral strictures.
Tillem SM; Press SM; Badlani GH
J Urol; 1997 May; 157(5):1665-8. PubMed ID: 9112501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
